
Growth Hormone Releasing Peptide · 5 mg/vial
Endogenous Growth Hormone Pathway Support
Provider-Guided Neuroendocrine Signaling & Cellular Longevity
Sermorelin is a growth hormone–releasing hormone (GHRH) analog that prompts the pituitary gland to produce and secrete growth hormone naturally. Rather than administering synthetic human growth hormone, sermorelin supports the body's own endocrine signaling pathways within normal physiological feedback controls. Consideration of treatment requires an individualized evaluation by a licensed medical provider.
Prescription-only medication. Requires an individualized telehealth evaluation and approval by a licensed healthcare provider. Not available for direct over-the-counter purchase.
Plan pricing and checkout will appear here once pharmacy availability and regulatory eligibility are confirmed.
HSA/FSA Payment Options — Eligibility Varies
Eligible healthcare purchases may qualify for payment using HSA or FSA funds, subject to plan requirements. Reimbursement is not guaranteed.
Clear, educational information about sermorelin peptide therapy — how it interacts with your body's growth hormone signaling system and what clinical oversight involves.
Sermorelin is a growth hormone–releasing hormone (GHRH) analog that interacts with pituitary somatotroph receptors, supporting the body's natural signaling pathway for growth hormone production.
It stimulates the anterior pituitary gland to release endogenous growth hormone in natural pulses, working within your body's normal regulatory feedback loops rather than supplying synthetic growth hormone directly.
A licensed medical provider conducts a thorough evaluation of your medical history, clinical concerns, and baseline health profile to determine whether sermorelin therapy is clinically appropriate.
Provider oversight ensures proper administration guidance, ongoing monitoring of treatment response, evaluation of potential side effects, and individualized follow-up throughout care.

Longevity & Cellular Support
Sermorelin is an analog of growth hormone–releasing hormone evaluated under physician supervision. A licensed medical provider conducts an individualized health evaluation to review your endocrine profile, clinical history, and whether peptide therapy aligns with your health objectives. Specific formulations and availability remain subject to pharmacy confirmation. This photograph is for illustrative purposes and does not represent a treatment outcome.
Sermorelin is a prescription-only medication. A licensed medical provider reviews your medical history, clinical concerns, and baseline health profile to determine whether sermorelin is appropriate and safe for you. Specific formulations, strengths, and availability remain subject to pharmacy confirmation. Compounded sermorelin medications are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality before marketing. This page is educational and not medical advice.
Interactive Illustration
Press Pulse to watch how a Sermorelin signal travels from the hypothalamus to the anterior pituitary, prompting a natural, pulsatile release of your body's own growth hormone — modulated by somatostatin feedback.
Feedback regulation: Natural somatostatin inhibition helps keep release within physiologic limits — sermorelin works upstream within these native feedback loops rather than introducing growth hormone directly.
Illustrative only — not a real hormone profile. Individual response is evaluated by a licensed provider.
Sermorelin is a prescription-only peptide medication requiring an individualized medical evaluation, clinical assessment, and approval by a licensed medical provider. Sermorelin is not FDA-approved for anti-aging, longevity, athletic performance, or general wellness. Compounded sermorelin formulations are not FDA-approved and have not been evaluated by the FDA for safety, effectiveness, or quality prior to marketing. Potential risks and side effects—including injection-site reactions, transient flushing, headache, dizziness, or peripheral edema—require thorough discussion with a licensed healthcare provider. Treatment is not appropriate for everyone, including individuals with active malignancies, untreated intracranial lesions, severe proliferative retinopathy, or known hypersensitivity to sermorelin or its excipients. Availability of compounded sermorelin depends on pharmacy confirmation, applicable state and federal regulations, and licensed provider authorization. All treatment options on this page remain subject to licensed-provider evaluation, prescription eligibility, pharmacy availability, and applicable laws. This information is educational only and does not constitute medical advice, diagnosis, or treatment. Always consult a licensed healthcare provider before beginning any peptide regimen.